Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (17116)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Sep 7, 2019 (publication date) through Dec 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Nicoletti A, Ponziani FR, Biolato M, Valenza V, Marrone G, Sganga G, Gasbarrini A, Miele L, Grieco A. Intestinal permeability in the pathogenesis of liver damage: From non-alcoholic fatty liver disease to liver transplantation. World J Gastroenterol 2019; 25(33): 4814-4834 [PMID: 31543676 DOI: 10.3748/wjg.v25.i33.4814] |
|---|---|
| URL: | https://www.wjgnet.com/2150-5349/full/v25/i33/4814.htm |
| Number | Citing Articles |
| 1 |
Célia Chamignon, Geoffroy Mallaret, Julie Rivière, Marthe Vilotte, Sead Chadi, Alejandra de Moreno de LeBlanc, Jean Guy LeBlanc, Frédéric Antonio Carvalho, Marco Pane, Pierre-Yves Mousset, Philippe Langella, Sophie Lafay, Luis G. Bermúdez-Humarán. Beneficial Effects of Lactobacilli Species on Intestinal Homeostasis in Low-Grade Inflammation and Stress Rodent Models and Their Implication in the Modulation of the Adhesive Junctional Complex. Biomolecules 2023; 13(9): 1295 doi: 10.3390/biom13091295
|
| 2 |
Ali Riza Caliskan, Mehmet Gul, Ismet Yılmaz, Baris Otlu, Nuray Uremis, Muhammed Mehdi Uremis, Ilkay Kilicaslan, Semir Gul, Deniz Tikici, Osman Saglam, Muhammed Yalcin, Ulvi Demirel, Murat Harputluoglu. Effects of larazotide acetate, a tight junction regulator, on the liver and intestinal damage in acute liver failure in rats. Human & Experimental Toxicology 2021; 40(12_suppl): S693 doi: 10.1177/09603271211058882
|
| 3 |
Yi Yuan, Xiyang Wang, Shun Huang, Hao Wang, Guoming Shen. Low-level inflammation, immunity, and brain-gut axis in IBS: unraveling the complex relationships. Gut Microbes 2023; 15(2) doi: 10.1080/19490976.2023.2263209
|
| 4 |
Dmitry Victorovich Garbuzenko. Pathophysiological mechanisms of hepatic stellate cells activation in liver fibrosis . World Journal of Clinical Cases 2022; 10(12): 3662-3676 doi: 10.12998/wjcc.v10.i12.3662
|
| 5 |
Jiahao Huang, Xinbo Sun, Yang Wang, Jianlong Su, Guangzhe Li, Xu Wang, Yuning Yang, Yuxuan Zhang, Bangjian Li, Guanyi Zhang, Jinrong Li, Jing Du, Roopa Hebbandi Nanjundappa, Channakeshava Sokke Umeshappa, Kun Shao. Biological interactions of polystyrene nanoplastics: Their cytotoxic and immunotoxic effects on the hepatic and enteric systems. Ecotoxicology and Environmental Safety 2023; 264: 115447 doi: 10.1016/j.ecoenv.2023.115447
|
| 6 |
Yiwei Dong, Qianqian Cai, Lisheng Fu, Haojie Liu, Mingzhe Ma, Xingzhong Wu, Tao Huang. Study of the G Protein Nucleolar 2 Value in Liver Hepatocellular Carcinoma Treatment and Prognosis. BioMed Research International 2021; 2021: 1 doi: 10.1155/2021/4873678
|
| 7 |
Pavlo Petakh, Valentyn Oksenych, Iryna Kamyshna, Iryna Boisak, Katerina Lyubomirskaya, Oleksandr Kamyshnyi. Exploring the complex interplay: gut microbiome, stress, and leptospirosis. Frontiers in Microbiology 2024; 15 doi: 10.3389/fmicb.2024.1345684
|
| 8 |
Victor Sánchez, Annette Brandt, Cheng Jun Jin, Dragana Rajcic, Anna Janina Engstler, Finn Jung, Anika Nier, Anja Baumann, Ina Bergheim. Fortifying Butterfat with Soybean Oil Attenuates the Onset of Diet-Induced Non-Alcoholic Steatohepatitis and Glucose Intolerance. Nutrients 2021; 13(3): 959 doi: 10.3390/nu13030959
|
| 9 |
Silvia Lopez-Escalera, Mari L. Lund, Gerben D. A. Hermes, Béatrice S.-Y. Choi, Kei Sakamoto, Anja Wellejus. In Vitro Screening for Probiotic Properties of Lactobacillus and Bifidobacterium Strains in Assays Relevant for Non-Alcoholic Fatty Liver Disease Prevention. Nutrients 2023; 15(10): 2361 doi: 10.3390/nu15102361
|
| 10 |
Alessio Ardizzone, Marika Lanza, Giovanna Casili, Michela Campolo, Irene Paterniti, Salvatore Cuzzocrea, Emanuela Esposito. Efficacy of a Novel Therapeutic, Based on Natural Ingredients and Probiotics, in a Murine Model of Multiple Food Intolerance and Maldigestion. Nutrients 2022; 14(11): 2251 doi: 10.3390/nu14112251
|
| 11 |
Fiorella D’Onofrio, Giorgia Renga, Matteo Puccetti, Marilena Pariano, Marina Maria Bellet, Ilaria Santarelli, Claudia Stincardini, Paolo Mosci, Maurizio Ricci, Stefano Giovagnoli, Claudio Costantini, Luigina Romani. Indole-3-Carboxaldehyde Restores Gut Mucosal Integrity and Protects from Liver Fibrosis in Murine Sclerosing Cholangitis. Cells 2021; 10(7): 1622 doi: 10.3390/cells10071622
|
| 12 |
Xu Zhang, Jing Chen, Shengmin Zhou, Yuanrong Jiang, Yong Wang, Ying Li. The effect of flaxseed oil after deep frying on lipid metabolism and gut barrier homeostasis. Food Research International 2024; 175: 113728 doi: 10.1016/j.foodres.2023.113728
|
| 13 |
Maria Cerreto, Francesco Santopaolo, Antonio Gasbarrini, Maurizio Pompili, Francesca Ponziani. Bariatric Surgery and Liver Disease: General Considerations and Role of the Gut–Liver Axis. Nutrients 2021; 13(8): 2649 doi: 10.3390/nu13082649
|
| 14 |
Doyeon Kim, Sangbin Han, Ju Dong Yang, Ji-Hye Kwon, Gyu-Sung Choi, Jong Man Kim, Yoon Joo Chung, Chisong Chung, Justin S. Ko, Mi Sook Gwak, Jae-Won Joh, Gaab Soo Kim. Bacterial contamination of autologous blood salvaged during deceased donor liver transplantation: a prospective observational study. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-76476-w
|
| 15 |
Tamilmani Periyasamy, V. V. Sathibabu Uddandrao, Chandrasekaran Ponnusamy, Saravanan Ganapathy, Sethumathi Ponnusamy Pudhupalayam, Sengottuvelu Singaravel, Ponmurugan Ponnusamy, Jagadeesan Ramasamy, Kalaivani Aiyasamy, Vadivukkarasi Sasikumar. Linalool Mitigated High-Fat Diet–Induced Non-alcoholic Fatty Liver Disease by Regulating the Intestinal-Hepatic Axis via TGF-β/NF-kB/TLR4/ZO-1 Pathway. Revista Brasileira de Farmacognosia 2023; 33(3): 617 doi: 10.1007/s43450-023-00395-6
|
| 16 |
Yang Ye, Yanan Liu, Kejun Cheng, Zufang Wu, Peng Zhang, Xin Zhang. Effects of Intestinal Flora on Irritable Bowel Syndrome and Therapeutic Significance of Polysaccharides. Frontiers in Nutrition 2022; 9 doi: 10.3389/fnut.2022.810453
|
| 17 |
Ji-Shuai Wang, Jin-Chun Liu. Intestinal microbiota in the treatment of metabolically associated fatty liver disease. World Journal of Clinical Cases 2022; 10(31): 11240-11251 doi: 10.12998/wjcc.v10.i31.11240
|
| 18 |
Andrei Dumitru, Elena Matei, Georgeta Camelia Cozaru, Anca Chisoi, Luana Alexandrescu, Răzvan Cătălin Popescu, Mihaela Pundiche Butcaru, Eugen Dumitru, Sorin Rugină, Cristina Tocia. Endotoxin Inflammatory Action on Cells by Dysregulated-Immunological-Barrier-Linked ROS-Apoptosis Mechanisms in Gut–Liver Axis. International Journal of Molecular Sciences 2024; 25(5): 2472 doi: 10.3390/ijms25052472
|
| 19 |
Irina Efremova, Roman Maslennikov, Elena Poluektova, Oleg Medvedev, Anna Kudryavtseva, George Krasnov, Maria Fedorova, Filipp Romanikhin, Maria Zharkova, Oxana Zolnikova, Gyunay Bagieva, Vladimir Ivashkin. Presepsin as a biomarker of bacterial translocation and an indicator for the prescription of probiotics in cirrhosis. World Journal of Hepatology 2024; 16(5): 822-831 doi: 10.4254/wjh.v16.i5.822
Abstract(258) |
Core Tip(239) |
Full Article(HTML)(906)
|
Full Article with Cover (PDF)-3851K(52)
|
Audio-711K(20)
|
Peer-Review Report-226K(44)
|
Answering Reviewers-34K(29)
|
Supplementary Material-129K(33)
|
Full Article (PDF)-857K(60)
|
Full Article (XML)-134K(28)
|
Times Cited (1)
|
Total Visits (2588)
|
Open
|
| 20 |
Luca Miele, Maria Adele Alberelli, Maurizio Martini, Antonio Liguori, Giuseppe Marrone, Alessandra Cocomazzi, Fabio Maria Vecchio, Raffaele Landolfi, Antonio Gasbarrini, Antonio Grieco, Erica De Candia. Nonalcoholic fatty liver disease (NAFLD) severity is associated to a nonhemostatic contribution and proinflammatory phenotype of platelets. Translational Research 2021; 231: 24 doi: 10.1016/j.trsl.2020.11.003
|
| 21 |
D. V. Garbuzenko. Pathophysiological Prerequisites and Therapeutic Potential of Fecal Microbiota Transplantation in Severe Alcoholic Hepatitis. The Russian Archives of Internal Medicine 2022; 12(5): 352 doi: 10.20514/2226-6704-2022-12-5-352-362
|
| 22 |
Indira Bhavsar‐Burke, Claire L. Jansson‐Knodell, Ashley C. Gilmore, David W. Crabb. Review article: the role of nutrition in alcohol‐associated liver disease. Alimentary Pharmacology & Therapeutics 2021; 53(12): 1268 doi: 10.1111/apt.16380
|
| 23 |
Federica Riva, Susanna Draghi, Alessia Inglesi, Joel Filipe, Paola Cremonesi, Antonio Lavazza, Patrizia Cavadini, Daniele Vigo, Stella Agradi, Laura Menchetti, Alessia Di Giancamillo, Lucia Aidos, Silvia Clotilde Modina, Nour Elhouda Fehri, Grazia Pastorelli, Valentina Serra, Claudia Maria Balzaretti, Marta Castrica, Marco Severgnini, Gabriele Brecchia, Giulio Curone. Bovine Colostrum Supplementation in Rabbit Diet Modulates Gene Expression of Cytokines, Gut–Vascular Barrier, and Red-Ox-Related Molecules in the Gut Wall. Animals 2024; 14(5): 800 doi: 10.3390/ani14050800
|
| 24 |
Maria Consiglia Bragazzi, Rosanna Venere, Anthony Vignone, Domenico Alvaro, Vincenzo Cardinale. Role of the Gut–Liver Axis in the Pathobiology of Cholangiopathies: Basic and Clinical Evidence. International Journal of Molecular Sciences 2023; 24(7): 6660 doi: 10.3390/ijms24076660
|
| 25 |
Kevin De Muynck, Bart Vanderborght, Hans Van Vlierberghe, Lindsey Devisscher. The Gut–Liver Axis in Chronic Liver Disease: A Macrophage Perspective. Cells 2021; 10(11): 2959 doi: 10.3390/cells10112959
|
| 26 |
Khadija A.M. Glal, Sahar M. El-Haggar, Sherief M. Abdel-Salam, Tarek M. Mostafa. Allopurinol Prevents Cirrhosis-Related Complications: A Quadruple Blind Placebo-Controlled Trial. The American Journal of Medicine 2024; 137(1): 55 doi: 10.1016/j.amjmed.2023.09.016
|
| 27 |
Changrui Long, Xiaoyan Zhou, Fan Xia, Benjie Zhou. Intestinal Barrier Dysfunction and Gut Microbiota in Non-Alcoholic Fatty Liver Disease: Assessment, Mechanisms, and Therapeutic Considerations. Biology 2024; 13(4): 243 doi: 10.3390/biology13040243
|
| 28 |
Anatoli M. Pershko, I. I. Yarovenko, V. A. Pershko. Metabolic basis for substantiation of nutrition therapy in chronic liver diseases. Experimental and Clinical Gastroenterology 2022; (7): 185 doi: 10.31146/1682-8658-ecg-203-7-185-191
|
| 29 |
Valeria Maccauro, Carlo Airola, Francesco Santopaolo, Antonio Gasbarrini, Francesca Romana Ponziani, Maurizio Pompili. Gut Microbiota and Infectious Complications in Advanced Chronic Liver Disease: Focus on Spontaneous Bacterial Peritonitis. Life 2023; 13(4): 991 doi: 10.3390/life13040991
|
| 30 |
Raz Abdulqadir, Jessica Engers, Rana Al-Sadi. Role of Bifidobacterium in Modulating the Intestinal Epithelial Tight Junction Barrier: Current Knowledge and Perspectives. Current Developments in Nutrition 2023; 7(12): 102026 doi: 10.1016/j.cdnut.2023.102026
|
| 31 |
Giulia Gibiino, Alessandro Sartini, Stefano Gitto, Cecilia Binda, Monica Sbrancia, Chiara Coluccio, Vittorio Sambri, Carlo Fabbri. The Other Side of Malnutrition in Inflammatory Bowel Disease (IBD): Non-Alcoholic Fatty Liver Disease. Nutrients 2021; 13(8): 2772 doi: 10.3390/nu13082772
|
| 32 |
Manvi Sharma, Itika Arora, Trygve O. Tollefsbol. Comprehensive Gut Microbiota. 2022; : 223 doi: 10.1016/B978-0-12-819265-8.00007-3
|
| 33 |
András Zóka, Béla Kádár, Eszter Vad. Fertőzésekhez kapcsolódó immunológiai jelenségek: a szürkezóna jelentősége. Orvosi Hetilap 2021; 162(38): 1526 doi: 10.1556/650.2021.32222
|
| 34 |
Marta Melis, Xiao-Han Tang, Steven E. Trasino, Lorraine J. Gudas. Retinoids in the Pathogenesis and Treatment of Liver Diseases. Nutrients 2022; 14(7): 1456 doi: 10.3390/nu14071456
|
| 35 |
Ahmed Mohamed ElGhandour, Essam Mohammed Bayoumy, Moataz Mohammed Sayed, Moheb Sharaby Eskandaros, Abdelmomen Momen Mohamed Emam, Nahla Mohamed Teama, Manal Sabry Mohamed, Sonya Ahmed El-Gaaly. Value of zonulin as a diagnostic and prognostic marker in different degrees of nonalcoholic fatty liver disease. Egyptian Liver Journal 2024; 14(1) doi: 10.1186/s43066-024-00351-6
|
| 36 |
Yin Zhu, Xiaozhi Wang, Lujian Zhu, Yulu Tu, Wanting Chen, Lingwen Gong, Tongtong Pan, Hongwei Lin, Jing Lin, Huiling Sun, Yuli Ge, Li Wei, Yu Guo, Caide Lu, Yongping Chen, Lanman Xu. Lactobacillus rhamnosus GG combined with inosine ameliorates alcohol-induced liver injury through regulation of intestinal barrier and Treg/Th1 cells. Toxicology and Applied Pharmacology 2022; 439: 115923 doi: 10.1016/j.taap.2022.115923
|
| 37 |
Roman Maslennikov, Vladimir Ivashkin, Irina Efremova, Elena Poluektova, Elena Shirokova. Probiotics in hepatology: An update. World Journal of Hepatology 2021; 13(9): 1154-1166 doi: 10.4254/wjh.v13.i9.1154
|
| 38 |
S. N. Mekhtiyev, O. A. Mekhtiyeva, O. M. Berko, A. M. Kolodkin. Role of increased intestinal permeability in the development and progression of liver diseases. Experimental and Clinical Gastroenterology 2023; (12): 130 doi: 10.31146/1682-8658-ecg-220-12-130-139
|
| 39 |
Maria Victoria Fernandez-Cantos, Diego Garcia-Morena, Valeria Iannone, Hani El-Nezami, Marjukka Kolehmainen, Oscar P. Kuipers. Role of microbiota and related metabolites in gastrointestinal tract barrier function in NAFLD. Tissue Barriers 2021; 9(3) doi: 10.1080/21688370.2021.1879719
|
| 40 |
Lijun Xue, Kaimin Li, Yanfei Jia, Dongxue Yao, Xuexing Guo, Shuhong Zhang. Impact of High-Temperature Feeds on Gut Microbiota and MAFLD. Journal of Microbiology and Biotechnology 2024; 34(9): 1789 doi: 10.4014/jmb.2405.05023
|
| 41 |
Doina Georgescu, Oana-Elena Ancusa, Daniel Azoulay, Ana Lascu, Ioana Ionita, Despina Calamar-Popovici, Mihai Ionita, Ciprian Ilie Rosca, Gelu-Mihai Brează, Daniela Reisz, Daniel Lighezan. Portal Vein Thrombosis in Patients with Liver Cirrhosis: What Went Wrong?. International Journal of General Medicine 2023; : 3889 doi: 10.2147/IJGM.S413438
|
| 42 |
Jeonghyeon Kwon, Chungho Lee, Sungbaek Heo, Bobae Kim, Chang-Kee Hyun. DSS-induced colitis is associated with adipose tissue dysfunction and disrupted hepatic lipid metabolism leading to hepatosteatosis and dyslipidemia in mice. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-84761-1
|
| 43 |
Xuehua An, Ruike Wang, Chong Cao, Dou Wang, Chen Chen, Yanhua Wang. Synergistic risk in the gut and liver: Insights into the toxic mechanisms and molecular interactions of combined exposure to triazophos and fenvalerate in zebrafish. Science of The Total Environment 2024; 948: 174710 doi: 10.1016/j.scitotenv.2024.174710
|
| 44 |
Kexin Tao, Han Peng, Xin Bi, Xiaoya Wang, Yue Tian, Hua Zhang, Yong Sun. Effect of Tetrastigma hemsleyanum leaves and Extract supplementation on liver metabolomics and the gut microbiota in alcohol-induced liver injury. Food Bioscience 2024; 58: 103617 doi: 10.1016/j.fbio.2024.103617
|
| 45 |
Joanna K. Hodges, Geoffrey Y. Sasaki, Richard S. Bruno. Anti-inflammatory activities of green tea catechins along the gut–liver axis in nonalcoholic fatty liver disease: lessons learned from preclinical and human studies. The Journal of Nutritional Biochemistry 2020; 85: 108478 doi: 10.1016/j.jnutbio.2020.108478
|
| 46 |
A. S. Ostrovskaya, M. V. Maevskaya. Sarcopenia and malnutrition in patients with liver diseases. Meditsinskiy sovet = Medical Council 2023; (18): 35 doi: 10.21518/ms2023-374
|
| 47 |
Galit Weinstein, Yochai Schonmann, Hanny Yeshua, Shira Zelber‐Sagi. The association between liver fibrosis score and incident dementia: A nationwide retrospective cohort study. Alzheimer's & Dementia 2024; 20(8): 5385 doi: 10.1002/alz.14033
|
| 48 |
Susana G. Rodrigues, Schalk van der Merwe, Aleksander Krag, Reiner Wiest. Gut-liver axis: Pathophysiological concepts and medical perspective in chronic liver diseases. Seminars in Immunology 2024; 71: 101859 doi: 10.1016/j.smim.2023.101859
|
| 49 |
Jie‐Lun Ku, Jia‐Rou Hsu, Yung‐Tsung Li, Li‐Ling Wu. Interplay among IL1R1, gut microbiota, and bile acids in metabolic dysfunction‐associated steatotic liver disease: a comprehensive review. Journal of Gastroenterology and Hepatology 2024; doi: 10.1111/jgh.16750
|
| 50 |
Toon J.I. De Munck, Pauline Verhaegh, Corinne Spooren, Zlatan Mujagic, Tobias Wienhold, Daisy Jonkers, Ad A.M. Masclee, Ger H. Koek, Jef Verbeek. Colonic permeability is increased in non-cirrhotic patients with nonalcoholic fatty liver disease. Digestive and Liver Disease 2023; 55(5): 614 doi: 10.1016/j.dld.2022.12.022
|
| 51 |
Shynggys Sergazy, Zarina Shulgau, Yevgeniy Kamyshanskiy, Zhaxybay Zhumadilov, Elena Krivyh, Alexander Gulyayev, Mohamad Aljofan. Blueberry and cranberry extracts mitigate CCL4-induced liver damage, suppressing liver fibrosis, inflammation and oxidative stress. Heliyon 2023; 9(4): e15370 doi: 10.1016/j.heliyon.2023.e15370
|
| 52 |
Francesca Romana Ponziani, Gaetano Coppola, Pierluigi Rio, Mario Caldarelli, Raffaele Borriello, Giovanni Gambassi, Antonio Gasbarrini, Rossella Cianci. Factors Influencing Microbiota in Modulating Vaccine Immune Response: A Long Way to Go. Vaccines 2023; 11(10): 1609 doi: 10.3390/vaccines11101609
|
| 53 |
Syeda Tasnim Quayum, Nusrat Jahan Ikbal Esha, Siam Siraji, Sanaa S. Al Abbad, Zainab H.A. Alsunaidi, Mansour H. Almatarneh, Shofiur Rahman, Abdullah N. Alodhayb, Khuloud A. Alibrahim, Sarkar M.A. Kawsar, Kabir M. Uddin. Exploring the effectiveness of flavone derivatives for treating liver diseases: Utilizing DFT, molecular docking, and molecular dynamics techniques. MethodsX 2024; 12: 102537 doi: 10.1016/j.mex.2023.102537
|
| 54 |
Kanav Kaushal, Samagra Agarwal, Sanchit Sharma, Pooja Goswami, Namrata Singh, Vikas Sachdev, Shekhar Poudel, Prasenjit Das, Rajni Yadav, Dinesh Kumar, Gaurav Pandey, Deepak Gunjan, Anoop Saraya. Demonstration of Gut-Barrier Dysfunction in Early Stages of Non-alcoholic Fatty Liver Disease: A Proof-Of-Concept Study. Journal of Clinical and Experimental Hepatology 2022; 12(4): 1102 doi: 10.1016/j.jceh.2022.01.006
|
| 55 |
Raquel Benedé-Ubieto, Francisco Javier Cubero, Yulia A. Nevzorova. Breaking the barriers: the role of gut homeostasis in Metabolic-Associated Steatotic Liver Disease (MASLD). Gut Microbes 2024; 16(1) doi: 10.1080/19490976.2024.2331460
|
| 56 |
Irina Efremova, Roman Maslennikov, Maria Zharkova, Elena Poluektova, Nona Benuni, Aleksandr Kotusov, Tatyana Demina, Aleksandra Ivleva, Farida Adzhieva, Taisiya Krylova, Vladimir Ivashkin. Efficacy and Safety of a Probiotic Containing Saccharomyces boulardii CNCM I-745 in the Treatment of Small Intestinal Bacterial Overgrowth in Decompensated Cirrhosis: Randomized, Placebo-Controlled Study. Journal of Clinical Medicine 2024; 13(3): 919 doi: 10.3390/jcm13030919
|
| 57 |
Francesco Santopaolo, Gaetano Coppola, Lucia Giuli, Antonio Gasbarrini, Francesca Romana Ponziani. Influence of Gut–Liver Axis on Portal Hypertension in Advanced Chronic Liver Disease: The Gut Microbiome as a New Protagonist in Therapeutic Management. Microbiology Research 2022; 13(3): 539 doi: 10.3390/microbiolres13030038
|
| 58 |
Marta Maestri, Francesco Santopaolo, Maurizio Pompili, Antonio Gasbarrini, Francesca Romana Ponziani. Gut microbiota modulation in patients with non-alcoholic fatty liver disease: Effects of current treatments and future strategies. Frontiers in Nutrition 2023; 10 doi: 10.3389/fnut.2023.1110536
|
| 59 |
Nasrin Mehranfard, Azadeh Yazdi, Asiye Rafiee Sardooi, Zeinab Shakerin, Maedeh Ghasemi. Honey protects against chronic unpredictable mild stress induced- intestinal barrier disintegration and hepatic inflammation. Molecular Biology Reports 2020; 47(11): 8475 doi: 10.1007/s11033-020-05888-4
|
| 60 |
Ludovico ABENAVOLI, Anna C. PROCOPIO, Emidio SCARPELLINI, Natale POLIMENI, Isabella AQUILA, Tiziana LARUSSA, Luigi BOCCUTO, Francesco LUZZA. Gut microbiota and non-alcoholic fatty liver disease. Minerva Gastroenterology 2022; 67(4) doi: 10.23736/S2724-5985.21.02896-5
|
| 61 |
Subhamay Adhikary, Akanksha Esmeeta, Amit Dey, Antara Banerjee, Biki Saha, Pournami Gopan, Asim K. Duttaroy, Surajit Pathak. Impacts of gut microbiota alteration on age-related chronic liver diseases. Digestive and Liver Disease 2024; 56(1): 112 doi: 10.1016/j.dld.2023.06.017
|
| 62 |
Titilayo Olotu, Jessica M. Ferrell. Lactobacillus sp. for the Attenuation of Metabolic Dysfunction-Associated Steatotic Liver Disease in Mice. Microorganisms 2024; 12(12): 2488 doi: 10.3390/microorganisms12122488
|
| 63 |
Guole Nie, Honglong Zhang, Danna Xie, Jun Yan, Xun Li. Liver cirrhosis and complications from the perspective of dysbiosis. Frontiers in Medicine 2024; 10 doi: 10.3389/fmed.2023.1320015
|
| 64 |
Shuang Gao, Muhammad Imran Khan, Fadia Kalsoom, Zhen Liu, Yanxin Chen, Zhengli Chen. Role of gene regulation and inter species interaction as a key factor in gut microbiota adaptation. Archives of Microbiology 2022; 204(6) doi: 10.1007/s00203-022-02935-5
|
| 65 |
Mauro Giuffrè, Michele Campigotto, Giuseppina Campisciano, Manola Comar, Lory Saveria Crocè. A story of liver and gut microbes: how does the intestinal flora affect liver disease? A review of the literature. American Journal of Physiology-Gastrointestinal and Liver Physiology 2020; 318(5): G889 doi: 10.1152/ajpgi.00161.2019
|
| 66 |
Roman Maslennikov, Vladimir Ivashkin, Irina Efremova, Elena Poluektova, Elena Shirokova. Gut-liver axis in cirrhosis: Are hemodynamic changes a missing link?. World Journal of Clinical Cases 2021; 9(31): 9320-9332 doi: 10.12998/wjcc.v9.i31.9320
|
| 67 |
Winston Hernández-Ceballos, Jacqueline Cordova-Gallardo, Nahum Mendez-Sanchez. Gut Microbiota in Metabolic-associated Fatty Liver Disease and in Other Chronic Metabolic Diseases. Journal of Clinical and Translational Hepatology 2021; 0(000): 000 doi: 10.14218/JCTH.2020.00131
|
| 68 |
Suling Zeng, Bernd Schnabl. Roles for the mycobiome in liver disease. Liver International 2022; 42(4): 729 doi: 10.1111/liv.15160
|
| 69 |
Damien Chua, Zun Siong Low, Guo Xiang Cheam, Aik Seng Ng, Nguan Soon Tan. Utility of Human Relevant Preclinical Animal Models in Navigating NAFLD to MAFLD Paradigm. International Journal of Molecular Sciences 2022; 23(23): 14762 doi: 10.3390/ijms232314762
|
| 70 |
Mohamad Jamalinia, Amedeo Lonardo, Ralf Weiskirchen. Sex and Gender Differences in Liver Fibrosis: Pathomechanisms and Clinical Outcomes. Fibrosis 2024; 2(1): 10006 doi: 10.70322/fibrosis.2024.10006
|
| 71 |
Stefania Del Fabbro, Philip C. Calder, Caroline E. Childs. Microbiota-independent immunological effects of non-digestible oligosaccharides in the context of inflammatory bowel diseases. Proceedings of the Nutrition Society 2020; 79(4): 468 doi: 10.1017/S0029665120006953
|
| 72 |
Fernando Vidal-Vanaclocha, Olatz Crende, Cira García de Durango, Alejandro Herreros-Pomares, Sandra López-Doménech, Álvaro González, Eva Ruiz-Casares, Thierry Vilboux, Riccardo Caruso, Hipólito Durán, Antonio Gil, Benedetto Ielpo, Fernando Lapuente, Yolanda Quijano, Emilio Vicente, Leticia Vidal-Lartitegui, Eduardo M. Sotomayor. Liver prometastatic reaction: Stimulating factors and responsive cancer phenotypes. Seminars in Cancer Biology 2021; 71: 122 doi: 10.1016/j.semcancer.2020.08.001
|
| 73 |
Leonard Kaps, Carolina Medina-Montano, Matthias Bros, Stephan Grabbe, Simon Johannes Gairing, Eva M. Schleicher, Stephan Gehring, Jörn M. Schattenberg, Peter R. Galle, Marcus-Alexander Wörns, Michael Nagel, Christian Labenz, Tomasz Brzozowski. Comparison of Inflammatory Cytokine Levels in Hepatic and Jugular Veins of Patients with Cirrhosis. Mediators of Inflammation 2023; 2023: 1 doi: 10.1155/2023/9930902
|
| 74 |
Mattia Paratore, Francesco Santopaolo, Giovanni Cammarota, Maurizio Pompili, Antonio Gasbarrini, Francesca Romana Ponziani. Fecal Microbiota Transplantation in Patients with HBV Infection or Other Chronic Liver Diseases: Update on Current Knowledge and Future Perspectives. Journal of Clinical Medicine 2021; 10(12): 2605 doi: 10.3390/jcm10122605
|
| 75 |
Tope Oyelade, Kevin P. Moore, Ali R. Mani. Physiological network approach to prognosis in cirrhosis: A shifting paradigm. Physiological Reports 2024; 12(13) doi: 10.14814/phy2.16133
|
| 76 |
Osamu Yoshino. Postinjury Multiple Organ Failure. Hot Topics in Acute Care Surgery and Trauma 2022; : 133 doi: 10.1007/978-3-030-92241-2_13
|
| 77 |
|
| 78 |
Cheng Zhao, Xiaoming Kao, Zhiwei Wang, Qinjie Liu, Jie Wu, Qiongyuan Hu, Xiuwen Wu, Jianan Ren. Biomimetic enzyme barrier for preventing intestine-derived LPS induced diseases. RSC Advances 2020; 10(15): 9126 doi: 10.1039/C9RA08721D
|
| 79 |
Yifan Guo, Lin Chang, Ge Zhang, Zhanyan Gao, Hao Lin, Yuting Zhang, Liang Hu, She Chen, Bing Fan, Si Zhang, Ruyi Xue. The role of Sphingomyelin synthase 2 (SMS2) in platelet activation and its clinical significance. Thrombosis Journal 2021; 19(1) doi: 10.1186/s12959-021-00282-x
|
| 80 |
Nicolás Ortiz-López, Catalina Fuenzalida, María Soledad Dufeu, Araceli Pinto-León, Alejandro Escobar, Jaime Poniachik, Juan Pablo Roblero, Lucía Valenzuela-Pérez, Caroll J. Beltrán. The immune response as a therapeutic target in non-alcoholic fatty liver disease. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.954869
|
| 81 |
Asra tus Saleha Siddiqui, Om Parkash, Syeda Amrah Hashmi. Malnutrition and liver disease in a developing country. World Journal of Gastroenterology 2021; 27(30): 4985-4998 doi: 10.3748/wjg.v27.i30.4985
|
| 82 |
Irina Efremova, Roman Maslennikov, Elena Poluektova, Oleg Medvedev, Anna Kudryavtseva, George Krasnov, Maria Fedorova, Filipp Romanikhin, Vyacheslav Bakhitov, Salekh Aliev, Natalia Sedova, Tatiana Kuropatkina, Anastasia Ivanova, Maria Zharkova, Ekaterina Pervushova, Vladimir Ivashkin. Gut Microbiota and Biomarkers of Endothelial Dysfunction in Cirrhosis. International Journal of Molecular Sciences 2024; 25(4): 1988 doi: 10.3390/ijms25041988
|
| 83 |
Roman Maslennikov, Aliya Alieva, Elena Poluektova, Yury Zharikov, Andrey Suslov, Yana Letyagina, Ekaterina Vasileva, Anna Levshina, Evgenii Kozlov, Vladimir Ivashkin. Sarcopenia in cirrhosis: Prospects for therapy targeted to gut microbiota. World Journal of Gastroenterology 2023; 29(27): 4236-4251 doi: 10.3748/wjg.v29.i27.4236
Abstract(679) |
Core Tip(606) |
Full Article(HTML)(3510)
|
Full Article with Cover (PDF)-2077K(115)
|
Full Article (Word)-351K(61)
|
Audio-395K(9)
|
Peer-Review Report-291K(70)
|
Answering Reviewers-97K(82)
|
Full Article (PDF)-967K(316)
|
Full Article (XML)-396K(87)
|
Times Cited (12)
|
Total Visits (7657)
|
Open
|
| 84 |
Piero Portincasa, Leonilde Bonfrate, Mohamad Khalil, Maria De Angelis, Francesco Maria Calabrese, Mauro D’Amato, David Q.-H. Wang, Agostino Di Ciaula. Intestinal Barrier and Permeability in Health, Obesity and NAFLD. Biomedicines 2021; 10(1): 83 doi: 10.3390/biomedicines10010083
|
| 85 |
Roberta Forlano, Giordano Sigon. A two-sample Mendelian randomization study to identity microbiome signatures in patients with Non-alcoholic fatty liver disease. Digestive and Liver Disease 2023; 55(11): 1462 doi: 10.1016/j.dld.2023.07.029
|
| 86 |
Luoyi Zhu, Xin Zong, Xiao Xiao, Yuanzhi Cheng, Jie Fu, Zeqing Lu, Mingliang Jin, Fengqin Wang, Yizhen Wang. Multi-Omics Analysis of the Gut-Liver Axis Reveals the Mechanism of Liver Injury in Colitis Mice. Frontiers in Immunology 2022; 12 doi: 10.3389/fimmu.2021.773070
|
| 87 |
So Yeong Cheon, Juhyun Song. Novel insights into non-alcoholic fatty liver disease and dementia: insulin resistance, hyperammonemia, gut dysbiosis, vascular impairment, and inflammation. Cell & Bioscience 2022; 12(1) doi: 10.1186/s13578-022-00836-0
|
| 88 |
Kylynda C. Bauer, Paula T. Littlejohn, Victoria Ayala, Anna Creus-Cuadros, B. Brett Finlay. Nonalcoholic Fatty Liver Disease and the Gut-Liver Axis: Exploring an Undernutrition Perspective. Gastroenterology 2022; 162(7): 1858 doi: 10.1053/j.gastro.2022.01.058
|
| 89 |
Salvatore Pezzino, Maria Sofia, Gloria Faletra, Chiara Mazzone, Giorgia Litrico, Gaetano La Greca, Saverio Latteri. Gut–Liver Axis and Non-Alcoholic Fatty Liver Disease: A Vicious Circle of Dysfunctions Orchestrated by the Gut Microbiome. Biology 2022; 11(11): 1622 doi: 10.3390/biology11111622
|
| 90 |
Lucia Cerrito, Francesco Santopaolo, Flavia Monti, Maurizio Pompili, Antonio Gasbarrini, Francesca Romana Ponziani. Advances in pharmacotherapeutics for hepatocellular carcinoma. Expert Opinion on Pharmacotherapy 2021; 22(10): 1343 doi: 10.1080/14656566.2021.1892074
|
| 91 |
Zhiqiang Yan, Fang Yang, Zhu Hong, Shishun Wang, Zhang Jinjuan, Bing Han, Rujia Xie, Feiyun Leng, Qin Yang. Blueberry Attenuates Liver Fibrosis, Protects Intestinal Epithelial Barrier, and Maintains Gut Microbiota Homeostasis. Canadian Journal of Gastroenterology and Hepatology 2019; 2019: 1 doi: 10.1155/2019/5236149
|
| 92 |
Marc Micó-Carnero, Carlos Rojano-Alfonso, Ana Isabel Álvarez-Mercado, Jordi Gracia-Sancho, Araní Casillas-Ramírez, Carmen Peralta. Effects of Gut Metabolites and Microbiota in Healthy and Marginal Livers Submitted to Surgery. International Journal of Molecular Sciences 2020; 22(1): 44 doi: 10.3390/ijms22010044
|
| 93 |
Swadha Anand, Sharmila S. Mande. Host-microbiome interactions: Gut-Liver axis and its connection with other organs. npj Biofilms and Microbiomes 2022; 8(1) doi: 10.1038/s41522-022-00352-6
|
| 94 |
Roberta Forlano, Benjamin H. Mullish, Lauren A. Roberts, Mark R. Thursz, Pinelopi Manousou. The Intestinal Barrier and Its Dysfunction in Patients with Metabolic Diseases and Non-Alcoholic Fatty Liver Disease. International Journal of Molecular Sciences 2022; 23(2): 662 doi: 10.3390/ijms23020662
|
| 95 |
Agostino Di Ciaula, Jacek Baj, Gabriella Garruti, Giuseppe Celano, Maria De Angelis, Helen H. Wang, Domenica Maria Di Palo, Leonilde Bonfrate, David Q-H Wang, Piero Portincasa. Liver Steatosis, Gut-Liver Axis, Microbiome and Environmental Factors. A Never-Ending Bidirectional Cross-Talk. Journal of Clinical Medicine 2020; 9(8): 2648 doi: 10.3390/jcm9082648
|
| 96 |
Yifei Zou, Xianjing Song, Ning Liu, Wei Sun, Bin Liu. Intestinal Flora: A Potential New Regulator of Cardiovascular Disease. Aging and disease 2022; 13(3): 753 doi: 10.14336/AD.2021.1022
|
| 97 |
Reem Z. Sharaiha, Scott Shikora, Kevin P. White, Guilherme Macedo, Jim Toouli, Lillian Kow. Summarizing Consensus Guidelines on Obesity Management. Journal of Clinical Gastroenterology 2023; 57(10): 967 doi: 10.1097/MCG.0000000000001916
|
| 98 |
A. S. Ostrovskaya, M. V. Maevskaya, K. M. Loban, M. S. Zharkova, M. P. Shapka, M. Yu. Nadinskaia, K. A. Gulyaeva, E. A. Vasiltsova, Yu. O. Chvileva, V. T. Ivashkin. Upper limb SMI for sarcopenia diagnosis in liver cirrhosis. Meditsinskiy sovet = Medical Council 2024; (15): 126 doi: 10.21518/ms2024-382
|
| 99 |
Naila Shoaib, Zaman Khan, Marukh Ibrahim, Anjam Hafeez, Arooj Fatima, Hassan Imran, Fiza Saleem, Syed Muhammad Hassan Askari, Sidra Gull. Dyslipidemia and impaired liver function biomarkers in patients with hepatitis B liver cirrhosis. Journal of Taibah University Medical Sciences 2023; 18(4): 748 doi: 10.1016/j.jtumed.2023.01.002
|
| 100 |
I. A. Krylova, A. V. Lyamin, V. I. Kupaev. Clinical improvement of some indicators of the activity of non-alcoholic fatty liver disease after correction of intestinal dysbiosis with dietary fiber. Experimental and Clinical Gastroenterology 2024; (2): 44 doi: 10.31146/1682-8658-ecg-222-2-44-49
|
| 101 |
Roman Maslennikov, Irina Efremova, Vladimir Ivashkin, Maria Zharkova, Elena Poluektova, Elena Shirokova, Konstantin Ivashkin. Effect of probiotics on hemodynamic changes and complications associated with cirrhosis: A pilot randomized controlled trial. World Journal of Hepatology 2022; 14(8): 1667-1677 doi: 10.4254/wjh.v14.i8.1667
|
| 102 |
Domenica Maria Di Palo, Gabriella Garruti, Agostino Di Ciaula, Emilio Molina-Molina, Harshitha Shanmugam, Maria De Angelis, Piero Portincasa. Increased Colonic Permeability and Lifestyles as Contributing Factors to Obesity and Liver Steatosis. Nutrients 2020; 12(2): 564 doi: 10.3390/nu12020564
|
| 103 |
Federica Di Vincenzo, Alberto Nicoletti, Marcantonio Negri, Federica Vitale, Lorenzo Zileri Dal Verme, Antonio Gasbarrini, Francesca Romana Ponziani, Lucia Cerrito. Gut Microbiota and Antibiotic Treatments for the Main Non-Oncologic Hepato-Biliary-Pancreatic Disorders. Antibiotics 2023; 12(6): 1068 doi: 10.3390/antibiotics12061068
|
| 104 |
Li Zhang, Zhiyi Zheng, Huanhuan Huang, Ya Fu, Tianbin Chen, Can Liu, Qiang Yi, Caorui Lin, Yongjun Zeng, Qishui Ou, Yongbin Zeng. Multi-omics reveals deoxycholic acid modulates bile acid metabolism via the gut microbiota to antagonize carbon tetrachloride-induced chronic liver injury. Gut Microbes 2024; 16(1) doi: 10.1080/19490976.2024.2323236
|
| 105 |
Darrick K. Li, Snehal N. Chaudhari, Yoojin Lee, Mozhdeh Sojoodi, Arijit A. Adhikari, Lawrence Zukerberg, Stuti Shroff, Stephen Cole Barrett, Kenneth Tanabe, Raymond T. Chung, A. Sloan Devlin. Inhibition of microbial deconjugation of micellar bile acids protects against intestinal permeability and liver injury. Science Advances 2022; 8(34) doi: 10.1126/sciadv.abo2794
|
| 106 |
Lucia Giuli, Marta Maestri, Francesco Santopaolo, Maurizio Pompili, Francesca Romana Ponziani. Gut Microbiota and Neuroinflammation in Acute Liver Failure and Chronic Liver Disease. Metabolites 2023; 13(6): 772 doi: 10.3390/metabo13060772
|
| 107 |
Camila Marques de Alcântara Barreto, Eliane Almeida do Valle, Jessica Pronestino de Lima Moreira, Katia Farias e Silva, Siane Lopes Bittencourt Rosas, Patrícia Teixeira Santana, Ana Maria Pittella, Gustavo Pereira, Flavia Ferreira Fernandes, Renata de Mello Perez, Heitor Siffert Pereira de Souza. Gut-related molecules as potential biomarkers in patients with decompensated cirrhosis. Annals of Hepatology 2025; 30(1): 101567 doi: 10.1016/j.aohep.2024.101567
|
| 108 |
Igor G. Bakulin, Inna A. Oganezova, Maria I. Skalinskaya, Ekaterina V. Skazyvaeva. Liver cirrosis and complication risk management. Terapevticheskii arkhiv 2021; 93(8): 963 doi: 10.26442/00403660.2021.08.200917
|
| 109 |
Carlo Smirne, Eleonora Croce, Davide Di Benedetto, Vincenzo Cantaluppi, Cristoforo Comi, Pier Paolo Sainaghi, Rosalba Minisini, Elena Grossini, Mario Pirisi. Oxidative Stress in Non-Alcoholic Fatty Liver Disease. Livers 2022; 2(1): 30 doi: 10.3390/livers2010003
|
| 110 |
Montserrat Rodríguez-Ayala, Carolina Donat-Vargas, Belén Moreno-Franco, Diana María Mérida, José Ramón Banegas, Fernando Rodríguez-Artalejo, Pilar Guallar-Castillón. Association of a healthy beverage score with total mortality in the adult population of Spain: A nationwide cohort study. PLOS Medicine 2024; 21(1): e1004337 doi: 10.1371/journal.pmed.1004337
|
| 111 |
|